Senior Management Team
Nick is an experienced CEO with over 20 years’experience in public listed and private companies operating internationally across the life sciences, healthcare diagnostic and biotechnology industries. Prior to joining Biofortuna, Nick was CEO of Source BioScience plc, the laboratory service and products business, where he helped grow revenues five fold, delivering an enterprise valued at more than £70 million. Nick holds a PhD in Mycology and is a Chartered Accountant, qualifying with KPMG. Nick is currently Chairman of Epistem Limited, the pre-clinical and clinical development CRO.
Nick is an experienced Chief Operating Officer in the life sciences and healthcare diagnostic sectors. Prior to joining Biofortuna, Nick was COO of Source BioScience plc for ten years, expanding the operations from a single site in the UK to ten facilities worldwide, integrating multiple acquisitions. Before Source BioScience, Nick was a co-founder of the genomics services and products company Geneservice and worked for over ten years in complex genetics and genomics; initially at Oxford University and then for the MRC at the Wellcome Trust Sanger Centre. Nick qualified as a microbiologist and worked in the NHS, completing a PhD on the molecular methods used to characterise outbreaks of bacterial meningitis.
Dave is a co-founder of Biofortuna, building on his R&D experience in developing complex genotyping solutions within Dynal / Invitrogen Transplant Diagnostics division. David specialised in developing and project managing key projects in macro and microarray technologies. He has a BSc in Genetics from the University of Liverpool.
Harry has over 18 years experience in commercial and operational roles in life sciences and diagnostic businesses. Prior to joining Biofortuna Harry was Director of Operations at London Genetics, Genotyping Project Manager at DxS, and Sales Manager at Whatman. Harry graduated in Manchester where he obtained a BSc in Biological Sciences and an MSc in Biomedical Sciences followed by positions in Clinical Genetics at Northwick Park Hospital and Manchester Royal Infirmary.
Paul is an experienced Sales Manager with over 15 years’ commercial experience gained in a range of highly competitive industries. Prior to joining Biofortuna, Paul spent 5 years at BBI Solutions, the IVD reagents and contract development business before moving onto Strategic Sales at Scapa Healthcare. Paul is currently undertaking his MBA Global with the University of Derby.
Ian is an experienced Quality Manager with over 20 years’ experience in managing quality systems within the life sciences and healthcare diagnostic sectors. Prior to joining Biofortuna Ian was UKAS Group Quality Manager at Concept Life Sciences, Quality Manager at ALS Life Sciences / ALcontrol and Quality Control Manager for Bio-Rad Laboratories. Ian is a Chartered Quality Professional and Member of the Royal Society of Chemistry.
Biofortuna Limited © 2019 |